Aurinia Pharmaceuticals (AUPH) PT Raised to $33 at H.C. Wainwright

July 22, 2020 11:14 AM EDT Send to a Friend
H.C. Wainwright analyst Ed Arce raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $33.00 (from $32.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login